{"symbol":"REGN","fiscalQuarter":"Q3-2008","reportDate":"2008-11-04","reportTime":"BMO","status":"reported","company":{"name":"Regeneron Pharmaceuticals, Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/REGN/earnings/Q3-2008","postBrief":{"headline":"Regeneron Pharmaceuticals Misses on EPS, Stock Down 0.55%","keyNumbers":[{"metric":"EPS","actual":"$-0.27","expected":"N/A","surprise":"+15.89%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management acknowledged challenges in the current market environment.","They emphasized ongoing investment in R&D despite the loss.","The focus remains on long-term growth and pipeline development."],"summary":"Management expressed concerns about market conditions impacting performance. They remain committed to their research and development efforts."},"guidanceChanges":{"summary":"No guidance was provided for future quarters.","changes":[]},"whatItMeans":"The earnings report indicates that Regeneron faced challenges, leading to a loss in EPS. The stock reacted negatively, dropping 0.55%, reflecting investor concerns about the company's current performance and market conditions. However, the slight EPS beat suggests some resilience in their operations.","metaDescription":"Regeneron Pharmaceuticals (REGN) Q3 2008 earnings: EPS missed. Stock down 0.55%. Full breakdown."}}